3D Systems and United Therapeutics Plan to Develop Solid-Organ Scaffolds

Today, 3D Systems, a company that's nearly synonymous with precision healthcare capabilities, and biotechnology company United Therapeutics Corporation announced a joint plan to develop solid-organ scaffolds for use in human transplants. The multi-year development and collaboration is a good fit, combining 3D Systems' healthcare and 3D printing expertise with the organ manufacturing and regenerative medicine proficiency of United Therapeutics. In addition to collaborating with United Therapeutics, 3D Systems will also work with its organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC, which is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company. Read more at 3DPrint.com: http://3dprint.com/172453/3d-print-s...gan-scaffolds/

http://3dprint.com/wp-content/uploads/2015/07/lung.png